Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
A randomized, double-blind, double placebo, parallel group, phase 4 clinical trial to compare the incidence of headache according to dosing regimen of Adinox® capsules in patients with transient ischemic attacks or ischemic stroke
100 Clinical Results associated with Chodang Pharm Co., Ltd.
0 Patents (Medical) associated with Chodang Pharm Co., Ltd.
100 Deals associated with Chodang Pharm Co., Ltd.
100 Translational Medicine associated with Chodang Pharm Co., Ltd.